xi

Xian Rongsheng Biotechnology Co., Ltd. is one of the renowned Exporter making Food & Beverages and many more China Alpha-arbutin, hyaluronic acid, Astaxanthin, lycopene, coenzyme Q10 products. The manufactory of Xian Rongsheng Biotechnology Co., Ltd. is located in Rm. 3-1917, I Duhui, No. 11, Tangyan South Rd Chengdu Sichuan *** China. Xian Rongsheng Biotechnology Co., Ltd. is a well-known organization in China that is operating transnationally. Xian Rongsheng Biotechnology Co., Ltd. Particulars Name: Mr. Jack Liu

xi

Xian Rongsheng Biotechnology Co., Ltd. can deliver high quality Herbal & Ayurvedic Product and many more China Alpha-arbutin, hyaluronic acid, Astaxanthin, lycopene, coenzyme Q10 goods, as they are a identified Wholesaler. The branch of Xian Rongsheng Biotechnology Co., Ltd. is placed in Rm. 3-1917, I Duhui, No. 11, Tangyan South Rd Zhengzhou Henan *** China. Xian Rongsheng Biotechnology Co., Ltd. is a finest business in China that is exporting universally. Xian Rongsheng Biotechnology Co., Ltd. Details Name: Mr. Jack Liu

xi

SHANGHAI, Oct 30 (Reuters) - China Rongsheng, the country’s largest private shipbuilder, has secured a cash lifeline that could be worth up to HK$3.23 billion dollars and is looking to change its name to reflect its shift into oil exploration.

Shares in heavily indebted Rongsheng, which were suspended on Aug. 29 after the company said it was in the process of restructuring, surged almost 17 percent higher after trading resumed on Thursday. They reversed gains, and were down 3.7 pct by 0217 GMT.

Rongsheng said late on Wednesday it would issue warrants worth HK$510 million to a Cayman Islands-incorporated investment firm wholly owned by private equity investor Wang Ping, which would entitle subscribers to buy up to 1.7 billion new shares at HK$1.60 each.

This would raise about HK$3.23 billion for Rongsheng, it said. A warrant entitles the holder to buy stock from the issuer at a specific price within a time frame.

The price of the new shares is at a 17.65 percent premium to Rongsheng’s closing price of HK$1.36 per share on Aug. 28, when it last previously traded. It said the subscription shares represent 19.36 percent of the firm’s issued share capital.

Rongsheng, which builds Brazilian miner’s Vale mega-iron ore carriers, came close to insolvency last year before clinching an agreement with banks to extend its loans until end-2015.

As one of the Jiangsu region’s largest employers, the firm has received copious support from the government, which is currently helping Rongsheng with its restructuring.

Rongsheng also said it had signed a debt agreement with a syndicate of domestic banks in Anhui province that would extend its debt payments to the end of 2015.

Rongsheng has been one of the most prolific casualties of the global shipping slump. The industry is still trying to shake off a glut of ships ordered before the crisis which has sunk freight rates and caused many shipbuilding orders to be delayed or cancelled. ($1 = 7.7552 Hong Kong dollar) ($1 = 6.1136 Chinese yuan) (Reporting by Brenda Goh; Editing by Miral Fahmy)

xi

Table 57. Shaanxi Fruiterco Biotechnology Co., Ltd. Pandan Leaf Extract Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)

Table 62. Herbasea Biotechnology (Xi"an) Co., Ltd. Pandan Leaf Extract Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)

Table 67. Xi"an Rongsheng Biotechnology Co., Ltd. Pandan Leaf Extract Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)

Table 82. Xi"an Prius biologicalEngineeringCo.Ltd Pandan Leaf Extract Production Capacity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)